Venous thromboembolism risk varies across hormonal contraceptives, according to a research letter published in JAMA.

The population of interest in our study included a very broad range of medical patients, and not just those with high-risk conditions. The risk among patients with known risk factors for VTE ...

Risk of VTE is estimated at 2% in all patients with IBD and as high as 8% during active IBD, which is about two to three times higher than in the general population, as Xu's group noted.

A fuller picture of protein S deficiency emerged with large-scale research showing the immense thrombotic risks faced by carriers of rare loss-of-function gene variants, though patients with ...

Objective: To evaluate the appropriateness of aspirin to prevent VTE in high-risk orthopedic surgery patients. Data sources: Guidelines published by the AAOS in 2011 and the ACCP in 2012 were ...

A new study from Denmark has found that men who use anabolic androgenic steroids (AAS) have a much higher risk of developing ...

"Venous thromboembolism, which include pulmonary ... The current subpopulation analysis included 12,211 patients in 11 high-risk groups -- head injury and an AIS score >2 (n=371), abdominal ...

Multivariate analysis identified elevated D-dimer levels (>750 ng/ml) and reduced serum albumin as independent risk factors ...

Venous Thromboembolism Treatment Market The venous Thromboembolism Treatment Market growth is driven by rising VTE prevalence, anticoagulan ...